Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension.

about

Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q42359702

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@en

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@nl

type

Item

label

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@en

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@nl

prefLabel

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@en

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@nl

P1476

Effect of iloprost on biomarke ...... lmonary arterial hypertension.

@en

P2093

Dan Tian

http://www.w3.org/2001/XMLSchema#string

Daxin Zhou

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Qian-Zhou Lv

http://www.w3.org/2001/XMLSchema#string

Xiao-Ye Li

http://www.w3.org/2001/XMLSchema#string

Xiaochun Zhang

http://www.w3.org/2001/XMLSchema#string

Yu Zheng

http://www.w3.org/2001/XMLSchema#string

Yuliang Long

http://www.w3.org/2001/XMLSchema#string

P2860

Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats

Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases

Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.

From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Uric Acid as a potential biomarker of pulmonary arterial hypertension in patients with sickle cell disease.

Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study.

Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.

P304

914-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1440-1681.12796

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28608969

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

biomarker

P932

5601287

http://www.w3.org/2001/XMLSchema#string